Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase Ι/Π Study of Stem Cell Therapy in Patients With Autism

NCT01343511 is registered in ClinicalTrials.gov with Shenzhen Beike Bio-Technology Co., Ltd. as lead sponsor.

NCT NCT01343511
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01343511 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase Ι/Π Study of Stem Cell Therapy in Patients With Autism
Lead sponsor
Shenzhen Beike Bio-Technology Co., Ltd.
Phase
Phase 1/2
Overall status
Completed
Start date
March 31, 2009
Completion date
May 31, 2011
Enrollment
37 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

autism